Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ADIR discloses compounds with high affinity for human D3 receptors

May 20, 1997

Cerebrovascular selectivity and vasospasmolytic action of AJ-3941

May 20, 1997

Krenitsky seeks partners for NGF modulators

May 19, 1997

Krenitsky seeks partners to develop MAO-A inhibitors

May 19, 1997

CoCensys enters licensing agreement with Wyeth-Ayerst for anxiety treatment

May 16, 1997

Briana Bio-Tech signs licensing agreement for chronic MS treatment

May 16, 1997

Cephalon and Chiron seek European approval of Myotrophin

May 15, 1997

Discovery licenses N-0923 transdermal patch to Yoshitomi

May 15, 1997

Elan to market Dainippon's zonisamide in North America

May 15, 1997

Glutamate antagonists from Warner-Lambert

May 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...